Galapagos

As promised, Gilead and Galapagos file filgotinib to FDA and get a speedy review
Fierce Biotech
Fri, 12/20/19 - 12:29 pm
Gilead Sciences
FDA
filgotinib
Galapagos
rheumatoid arthritis
Trials of Novartis' Dupixent rival bet scrapped by MorphoSys, Galapagos
Fierce Biotech
Tue, 10/29/19 - 09:57 am
MorphoSys
Galapagos
Novartis
MOR106
atopic dermatitis
Dupixent
Sanofi
Gilead, Galapagos share 52-week update on filgotinib
Fierce Biotech
Fri, 10/11/19 - 10:44 am
Gilead Sciences
Galapagos
filgotinib
clinical trials
rheumatoid arthritis
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
EP Vantage
Tue, 10/8/19 - 10:53 am
M&A
Lundbeck
Alder Biopharmaceuticals
Gilead Sciences
Galapagos
Vertex Pharmaceuticals
Semma
Swedish Orphan Biovitrum
Dova Pharmaceuticals
Novartis
IFM
Chasing AbbVie, Gilead files for approval of filgotinib in Japan
Fierce Biotech
Tue, 10/8/19 - 09:40 am
Gilead Sciences
JAK inhibitors
Japan
filgotinib
Galapagos
AbbVie
Gilead, Galapagos finalise £4.1bn research and development deal
Pharmaceutical Business Review
Mon, 08/26/19 - 09:21 am
Gilead Sciences
Galapagos
R&D
Gilead looks to Galapagos deal to double research capacity
Fierce Biotech
Wed, 07/31/19 - 10:20 am
Gilead Sciences
Daniel O'Day
Galapagos
R&D
Looking to resolve lingering doubts, Gilead unleashes a $5B late-stage cash alliance with Galapagos
Endpoints
Sun, 07/14/19 - 04:01 pm
Gilead Sciences
Galapagos
IPF
osteoarthritis
Upcoming events – Crucial data on zanubrutinib and filgotinib approach
EP Vantage
Fri, 06/14/19 - 10:14 am
BeiGene
Waldenström’s macroglobulinemia
zanubrutinib
Galapagos
filgotinib
CLE
Sjögren’s syndrome
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
Sun, 06/9/19 - 01:36 pm
ADA
Merck
Keytruda
NGM Biopharmaceuticals
NGM313/MK-3655
Corbus Pharmaceuticals
Nektar
Galapagos
Kezar Life Sciences
Kura Oncology
Bluebird Bio
BeiGene
Global Blood Therapeutics
Blueprint Medicines
Regeneron
Arqule
Sunesis
Sutro BioPharma
Incyte
Geron
Forty Seven
2 Biotech Stocks With Major Incoming Catalysts
Yahoo/Motley Fool
Thu, 03/7/19 - 09:52 am
Axsome Therapeutics
AXS-05
depression
Galapagos
filgotinib
Gilead Sciences
rheumatoid arthritis
Evotec, Galapagos enter into collaboration in fibrosis field
Pharmaceutical Business Review
Mon, 02/11/19 - 10:22 am
fibrosis
Evotec
Galapagos
Galapagos continues fibrosis pipeline buildout with Evotec deal
Fierce Biotech
Thu, 02/7/19 - 09:28 am
Galapagos
Evotec
fibrosis
R&D
Gilead can now attempt at takeover of Galapagos
GoinPharma
Sat, 12/1/18 - 12:22 pm
Gilead Sciences
Galapagos
M&A
Could Gilead and Galapagos' JAK inhibitor lead the class? Wall Street thinks it has a chance.
Biopharma Dive
Mon, 11/26/18 - 11:13 pm
Gilead Sciences
Galapagos
JAK inhibitors
rheumatoid arthritis
filgotinib
Galapagos CEO says a sale to Gilead is 50% likely
GoinPharma
Mon, 11/5/18 - 11:50 am
Galapagos
M&A
Gilead Sciences
AbbVie Takes Over Galapagos Cystic Fibrosis Collaboration Instead of Walking Away
BioSpace
Thu, 10/25/18 - 11:35 am
AbbVie
Galapagos
cystic fibrosis
Up on Deck! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/20/18 - 11:16 pm
earnings
biotech
Biogen
Alexion Pharmaceuticals
Bristol-Myers Squibb
Celgene
Gilead Sciences
Merck
Biomarin
Galapagos
Seattle Genetics
Dr Reddy's
Galapagos opposes takeover attempt by Gilead
GoinPharma
Fri, 09/14/18 - 11:02 am
Galapagos
Gilead Sciences
M&A
Galapagos shares surge on RA drug trial results
Pharmaforum
Thu, 09/13/18 - 10:02 am
Gilead Sciences
Galapagos
filgotinib
rheumatoid arthritis
clinical tgrials

Pages